Htg Molecular Diagnostics
(NASDAQ) HTGM
Htg Molecular Diagnostics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$6.21M
Net Income (TTM)
$20.15M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
HTGM News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Htg Molecular Diagnostics
Industry
Health Care Technology
Sector
Health CareEmployees
53
CEO
John L. Lubniewski
Website
www.htgmolecular.comHeadquarters
Tucson, AZ 85706, US
HTGM Financials
Key Financial Metrics (TTM)
Gross Margin
28%
Operating Margin
-3%
Net Income Margin
-3%
Return on Equity
-3%
Return on Capital
-2%
Return on Assets
-1%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$1.79M
Operating Income
$20.83M
EBITDA
$20.14M
Operating Cash Flow
$18.41M
Capital Expenditure
$23.04K
Free Cash Flow
$18.43M
Cash & ST Invst.
$12.21M
Total Debt
$4.83M
Htg Molecular Diagnostics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.03M
-12.8%
Gross Profit
$117.10K
-135.5%
Gross Margin
-11.34%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
53
N/A
Net Income
$5.05M
+22.2%
EBITDA
$4.83M
+20.4%
Quarterly Fundamentals
Net Cash
$2.58M
-78.6%
Accounts Receivable
$1.13M
+51.1%
Inventory
$654.92K
-67.6%
Long Term Debt
$423.24K
-89.5%
Short Term Debt
$3.56M
-34.4%
Return on Assets
-1.21%
N/A
Return on Invested Capital
-2.19%
N/A
Free Cash Flow
$4.37M
+26.5%
Operating Cash Flow
$4.36M
+26.5%